##plugins.themes.bootstrap3.article.main##

Three elderly patients received sugammadex after confirmation of train-of-four (TOF) stimulation at the end of the surgery. They presented opioid-induced respiratory depression accompanied by severe acidosis postoperatively. Even after the reversal of opioid intoxication with naloxone, the respiration did not recover, and TOF revealed recurrent paralysis. Two of three cases completely recovered after additional sugammadex administration, but remnant 1 case without sugammadex transferred to intensive care unit with intubated status. Even if the recommended dose of sugammadex is administered, there can be recurrent neuromuscular blockade by complicated reasons. Continuous quantitative neuromuscular monitoring may be needed to prevent these unusual situations.

Downloads

Download data is not yet available.

References

  1. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103(4):695-703.
    DOI  |   Google Scholar
  2. de Kam PJ, Nolte H, Good S, Yunan M, Williams-Herman DE, Burggraaf J, et al. Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers. Br J Anaesth. 2018;121(4):758-67.
    DOI  |   Google Scholar
  3. Uzawa K, Seki H, Yorozu T. Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report. BMC Anesthesiol. 2021;21(1):154.
    DOI  |   Google Scholar
  4. Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth. 2011;58(10):944-7.
    DOI  |   Google Scholar
  5. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117(2):345-51.
    DOI  |   Google Scholar
  6. Loupec T, Frasca D, Rousseau N, Faure JP, Mimoz O, Debaene B. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients. Anaesthesia. 2016;71(3):265-72.
    DOI  |   Google Scholar
  7. Kaufhold N, Schaller SJ, Stauble CG, Baumuller E, Ulm K, Blobner M, et al. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20). Brit J Anaesth. 2016;116(2):233-40.
    DOI  |   Google Scholar
  8. Pongracz A, Szatmari S, Nemes R, Fulesdi B, Tassonyi E. Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation. Anesthesiology. 2013;119(1):36-42.
    DOI  |   Google Scholar
  9. Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology. 2010;113(5):1054-60.
    DOI  |   Google Scholar
  10. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63(4):440-3.
    DOI  |   Google Scholar
  11. Eikermann M, Groeben H, Husing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology. 2003;98(6):1333-7.
    DOI  |   Google Scholar
  12. Aziz L, Ono K, Ohta Y, Morita K, Hirakawa M. The effect of CO2-induced acid-base changes on the potencies of muscle relaxants and antagonism of neuromuscular block by neostigmine in rat in vitro. Anesth Analg. 1994;78(2):322-7.
    DOI  |   Google Scholar
  13. Baraka A. pH and muscle relaxants. Anesthesiology. 1992;76(2):320.
    DOI  |   Google Scholar